cancer-related cachexia
Conditions
Interventions
Very high liver uptake group (HG):None
Very low liver uptake group (LG):None
Control group:None
Sponsors
China National Nuclear Corporation 416 Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Healthy individuals without a history of malignant tumors, liver disease, biliary disease, or diabetes, and whose pre-FDG-injection blood glucose level is <=200 mg/dL; 2.Patients without any laboratory data within 10 days prior to the PET/CT study; 3.Cancer patients aged 18 years or older; 4.Patients who underwent 18F-FDG PET/CT scanning with complete imaging data and clinical records; 5.Patients who are able to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with liver tumors; 2.patients with blood glucose levels greater than 200 mg/dL; 3.patients younger than 18 years of age; 4.patients with extensive high metabolic lesions and reduced brain FDG uptake; 5.patients with other severe systemic diseases that may affect the study outcomes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hepatic FDG uptake quantified by PET/CT imaging parameters such as SUVmax and SUVmean.;Overall Survival (OS);Disease-Free Survival (DFS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Laboratory nutritional and metabolic biomarkers;BMI; | — |
Countries
China
Contacts
Public ContactYuxiao Xia
China National Nuclear Corporation 416 Hospital
Outcome results
None listed